Increases in bone turnover marker levels at an early phase after starting zoledronic acid predicts skeletal-related events in patients with prostate cancer with bone metastasis
Kouji Izumi, Atsushi Mizokami, Shingo Itai, Takashi Shima, Kazuyoshi Shigehara, Sotaro Miwa, Yuji Maeda, Hiroyuki Konaka, Eitetsu Koh, Mikio NamikiVolume:
109
Year:
2012
Language:
english
Pages:
7
DOI:
10.1111/j.1464-410x.2011.10192.x
File:
PDF, 339 KB
english, 2012